Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
| Pronunciation: | TEM sir OH li mus |
| Brand: | Torisel |
![]() |
You should not use this medication if you are allergic to temsirolimus or if you have severe liver disease. |
![]() |
Do not use temsirolimus if you are pregnant. It could harm the unborn baby. Use an effective form of birth control while you are using this medication and for at least 3 months after your treatment ends. |
If a man fathers a child while using this medication, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment. Continue using condoms for at least 3 months after you stop using temsirolimus.
Before you receive temsirolimus, tell your doctor if you have liver disease, high cholesterol, diabetes, an allergy to sirolimus (Rapamune), or a history of head injury, stroke, or brain tumor.
![]() |
Temsirolimus can lower blood cells that help your body fight infections. Your blood may need to be tested often. Avoid being near people who are sick or have infections. Do not receive a live vaccine. Tell your doctor at once if you develop signs of infection. |
There are many other drugs that can interact with temsirolimus. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor. Keep a list of all your medicines and show it to any healthcare provider who treats you.
Temsirolimus is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Temsirolimus is used to treat cancer of the kidneys, also called renal cell carcinoma.
Temsirolimus may also be used for purposes not listed in this medication guide.
![]() |
You should not use this medication if you are allergic to temsirolimus or if you have severe liver disease. |
To make sure you can safely receive temsirolimus, tell your doctor if you have any of these other conditions:
![]() |
FDA pregnancy category D. Do not use temsirolimus if you are pregnant. It could harm the unborn baby. Use effective birth control while you are using this medication and for at least 3 months after your treatment ends. |
If a man fathers a child while using this medication, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment. Continue using condoms for at least 3 months after you stop using temsirolimus.
![]() |
It is not known whether temsirolimus passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using temsirolimus. |
Temsirolimus is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Temsirolimus must be given slowly, and the IV infusion can take up to 60 minutes to complete.
Temsirolimus is usually given once each week unless your cancer progresses or you have serious side effects from the medication.
You may receive other medications before your temsirolimus infusion. These medications will help prevent certain side effects.
![]() |
Temsirolimus can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. Your blood may need to be tested often. Your kidney function may also need to be tested. Visit your doctor regularly. |
![]() |
If you need surgery, tell the surgeon ahead of time that you are using temsirolimus. You may need to stop using the medicine for a short time. |
Call your doctor if you miss an appointment for your temsirolimus injection.
![]() |
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. |
Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
![]() |
Do not receive a "live" vaccine while using temsirolimus, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. Live vaccines include measles, mumps, rubella (MMR), Bacillus Calmette-Guérin (BCG), oral polio, rotavirus, smallpox, typhoid, yellow fever, varicella (chickenpox), H1N1 influenza, and nasal flu vaccine. |
Grapefruit and grapefruit juice may interact with temsirolimus and lead to potentially dangerous effects. Discuss the use of grapefruit products with your doctor.
![]() |
Some people receiving a temsirolimus injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, warm, tingly, light-headed, short of breath, or have chest pain or trouble breathing during the injection. |
![]() |
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. |
![]() |
Call your doctor at once if you have a serious side effect such as: |
Less serious side effects include mild skin rash
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medicines you use, especially:
This list is not complete and there are many other drugs that can interact with temsirolimus. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor. Keep a list of all your medicines and show it to any healthcare provider who treats you.
Your doctor or pharmacist can provide more information about temsirolimus.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 2.01. Revision date: 9/20/2011.
Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by clicking on this link.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @drdavidpearce: Early trigger for #alzheimers http://t.co/aQnGFDHYnT reported might be a target for #neurodegenerative & #rarediseases